Cabozantinib for patients with advanced hepatocellular carcinoma: a cost-effectiveness analysis

by Amir Shlomai, Moshe Leshno, Daniel A. Goldstein
Published 2019-09-01

Regorafenib treatment for patients with hepatocellular carcinoma who progressed on sorafenib-A cost-effectiveness analysis.

by Amir Shlomai, Moshe Leshno, Daniel A Goldstein
Published 2018-01-01

Cost effectiveness and affordability of trastuzumab in sub-Saharan Africa for early stage HER2-positive breast cancer

by Noga Gershon, Yakir Berchenko, Peter S. Hall, Daniel A. Goldstein
Published 2019-02-01

Transitional Cell Carcinoma and Pseudocirrhosis— A Case Report and Review of the Literature

by Gilad Borisovsky, Daniel A. Goldstein, Noa Eliakim-Raz, Shlomit R. Tamir
Published 2020-08-01

Potential Association between Kaposi Sarcoma and Gout: An Exploratory Observational Study

by Assaf Moore, Idit Peretz, Lilach Yosef, Daniel A. Goldstein, Hadar Goldvaser, Suzanna Horn, Yonatan Edel, Alona Zer
Published 2020-01-01

The concordance of treatment decision guided by OncotypeDX and the PREDICT tool in real‐world early‐stage breast cancer

by Daniel A. Goldstein, Chen Mayer, Tzippy Shochat, Daniel Reinhorn, Assaf Moore, Michal Sarfaty, Rinat Yerushalmi, Hadar Goldvaser
Published 2020-07-01

The Financial Impact of Hypofractionated Radiation for Localized Prostate Cancer in the United States

by Assaf Moore, Ido Stav, Robert B. Den, Noa Gordon, Michal Sarfaty, Victoria Neiman, Eli Rosenbaum, Daniel A. Goldstein
Published 2019-01-01

Chemotherapy Used to Halt Lower GI Bleeding in a Rare Case of Metastatic Choriocarcinoma to the GI Tract

by Ralph Kamel, Talal Seoud, Teniola Oluwadamilola, Michael Karass, Emily Grossniklaus, Gabriela Oprea-Ilies, Daniel A. Goldstein, Sanjay Jain
Published 2016-01-01